Latest news with #RobinHoodFoundation
The Citizen
25-05-2025
- General
- The Citizen
Foundation hosts fundraiser for animals
THE Robin Hood Foundation (RHF) has raised R25 000 towards an upcoming community dog sterilisation programme. The programme which will be held during the school holidays is a collaboration between The Kloof and Highway SPCA, Friend of K9 Trust and the Robin Hood Foundation. Robin Hood Foundation chairperson Cindy Norcott said the community clinic will see the sterilisation and treatment of more than 150 dogs free of charge. 'This will have a major impact on reducing the number of stray animals in the community. I would like to thank Dalgen Packaging and Janine Southwood for their support and generosity.' Also read: Woman convicted in cat cruelty horror Norcott started the Robin Hood Foundation 20 years ago. It runs more than 180 community projects per year aimed at impacting people and animals in impoverished communities. The foundation's projects are Bless a Granny, the Sarmie Army, Love the Babies, Gogo Bags and the Mahala Markets. Kloof and Highway SPCA manager Barbara Patrick said, 'The Kloof and Highway SPCA would like to thank everyone who supported the Robin Hood Foundation fundraiser at the Kloof Country Club; it was a fun, interactive and fabulous morning. 'The money that was raised will be used to host an Outreach Clinic from July 14-18. During this week community members' pets will be sterilised, treated and we will educate the community and especially the children who are our future leaders and pet owners. 'All animals that are sterilised will go home after being sterilised, vaccinated and treated for parasites. We also send these pets, and their owners, home with food blankets and treats for the family.' If anyone would like to get involved with RHF projects they can contact Charlotte at info@ or visit For more from the Highway Mail, follow us on Facebook , X and Instagram. You can also check out our videos on our YouTube channel or follow us on TikTok. Click to subscribe to our newsletter here At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Yahoo
10-05-2025
- Business
- Yahoo
DXC Technology Company (DXC): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Larry Robbins' 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where DXC Technology Company (NYSE:DXC) stands against other stock picks with huge upside potential. Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000. The firm manages capital for investors across a range of private investment funds. Robbins is currently the CEO of his firm. He graduated with honors from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania in 1992 and earned a BS in economics with concentrations in accounting, finance, and marketing. He also has a BS in engineering with a major in systems engineering. He became a Certified Public Accountant in Illinois in 1991. Before founding Glenview Capital, Robbins worked as a portfolio manager at Omega Advisors, which is a prominent hedge fund founded by Leon Cooperman. In 2017, Larry Robbins also began serving as chairman of the Robin Hood Foundation, which fights poverty in New York City. Through his Family Foundation, he is an active supporter of education reform both in NYC and on the national level. He also serves as Chairman of the Board of KIPP NY and is a Board Member of Zearn and Relay Graduate School of Education. Due to his sharp analytical skills and a focus on the healthcare sector, Robbins has built a reputation as one of the most influential figures in the hedge fund industry. Glenview Capital Management has 6 clients and discretionary assets under management (AUM) of $5.6 billion as reported in its Form ADV dated 4 March 2025. The last reported 13F filing for Q4 2024 included $3.95 billion in managed 13F securities and a top 10 holdings concentration of 65.22%. Earlier in September 2024, Institutional Investor reported that Glenview Capital Management was on track for its best year in 5 years. The flagship Glenview Capital Partners fund was up 3.45% in August 2024 and 17.2% through the first 8 months of the year. One of the reasons behind this performance is the hedge fund's diversification away from a historically heavy concentration in healthcare stocks. Glenview Capital Management has now expanded its investments into the tech sector and other industries. Larry Robbins believes in a straightforward investment strategy: 'There are only two things that matter in investing. What are they going to earn, and what multiple are people going to put on that. Let's not make our business any more complicated than this.' To compile the list of billionaire Larry Robbins' 10 stock picks with huge upside potential, we sifted through Q4 2024 13F filings of Glenview Capital from Insider Monkey. From these filings, we checked the upside potential from CNN for the top 30 stock picks and ranked the stocks in ascending order of this upside potential. We have also added Glenview Capital's stake in each stock as well as the broader hedge fund sentiment for it. Note: All data was sourced on May 8. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). An IT security specialist inspecting a corporate network server for any malicious activity. Glenview Capital's Stake: $157.6 million Number of Hedge Fund Holders: 24 Average Upside Potential as of May 8: 42.30% DXC Technology Company (NYSE:DXC) provides information technology services and solutions. It operates in two segments: Global Business Services and Global Infrastructure Services. The company markets and sells its products through a direct sales force to commercial businesses and public sector enterprises. DXC experienced an overall organic revenue decline of 4.2% year-over-year in FQ3 2025, with Global Business Services making up 52% of total revenue generated. This segment showed relative stability with only a 0.5% organic revenue decrease. This segment is focused on driving digital transformations for clients through scalable and standardized solutions. Enterprise Applications saw increased bookings due to AI capabilities, particularly within consulting and engineering. This was fueled by expanding software license revenue. DXC Technology Company (NYSE:DXC) is now investing in training client partners and refining performance management to expand the Global Business Services pipeline and grow future bookings, with a healthy book-to-bill ratio of 1.23x in Q3. Overall, DXC ranks 6th on our list of billionaire Larry Robbins' stock picks with huge upside potential. While we acknowledge the potential of DXC as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DXC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
10-05-2025
- Business
- Yahoo
Western Digital Corporation (WDC): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Larry Robbins' 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Western Digital Corporation (NASDAQ:WDC) stands against other stock picks with huge upside potential. Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000. The firm manages capital for investors across a range of private investment funds. Robbins is currently the CEO of his firm. He graduated with honors from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania in 1992 and earned a BS in economics with concentrations in accounting, finance, and marketing. He also has a BS in engineering with a major in systems engineering. He became a Certified Public Accountant in Illinois in 1991. Before founding Glenview Capital, Robbins worked as a portfolio manager at Omega Advisors, which is a prominent hedge fund founded by Leon Cooperman. In 2017, Larry Robbins also began serving as chairman of the Robin Hood Foundation, which fights poverty in New York City. Through his Family Foundation, he is an active supporter of education reform both in NYC and on the national level. He also serves as Chairman of the Board of KIPP NY and is a Board Member of Zearn and Relay Graduate School of Education. Due to his sharp analytical skills and a focus on the healthcare sector, Robbins has built a reputation as one of the most influential figures in the hedge fund industry. Glenview Capital Management has 6 clients and discretionary assets under management (AUM) of $5.6 billion as reported in its Form ADV dated 4 March 2025. The last reported 13F filing for Q4 2024 included $3.95 billion in managed 13F securities and a top 10 holdings concentration of 65.22%. Earlier in September 2024, Institutional Investor reported that Glenview Capital Management was on track for its best year in 5 years. The flagship Glenview Capital Partners fund was up 3.45% in August 2024 and 17.2% through the first 8 months of the year. One of the reasons behind this performance is the hedge fund's diversification away from a historically heavy concentration in healthcare stocks. Glenview Capital Management has now expanded its investments into the tech sector and other industries. Larry Robbins believes in a straightforward investment strategy: 'There are only two things that matter in investing. What are they going to earn, and what multiple are people going to put on that. Let's not make our business any more complicated than this.' To compile the list of billionaire Larry Robbins' 10 stock picks with huge upside potential, we sifted through Q4 2024 13F filings of Glenview Capital from Insider Monkey. From these filings, we checked the upside potential from CNN for the top 30 stock picks and ranked the stocks in ascending order of this upside potential. We have also added Glenview Capital's stake in each stock as well as the broader hedge fund sentiment for it. Note: All data was sourced on May 8. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). A data center filled with racks of hard disk drives and solid state drives. Glenview Capital's Stake: $41.67 million Number of Hedge Fund Holders: 85 Average Upside Potential as of May 8: 30.93% Western Digital Corporation (NASDAQ:WDC) designs, manufactures, and sells data storage devices and solutions. It offers a broad portfolio of products, including hard disk drives (HDDs), solid-state drives (SSDs), flash memory, and data storage platforms. It serves customers across various markets, including consumer electronics, data centers, and industrial applications. The company experienced a 5% sequential decline in its FQ3 2025 revenue. The consumer segment, client segment, and cloud segment each fell by 13%, 2%, and 4%, respectively. Earlier in February, Western Digital completed the separation of the Flash business unit (Sandisk), which has introduced a transition period and potential instability. External factors, such as the current global economic and geopolitical uncertainty and shifting trade dynamics, also influence the company's business operations. However, Western Digital Corporation's (NASDAQ:WDC) Cloud end market generated $2 billion in revenue, which made up 87% of the company's total revenue. This was up 38% year-over-year, which was fueled by the increasing need for mass storage solutions driven by the growth of data due to enterprise workloads and the surge in AI-generated content. Parnassus Mid Cap Fund stated the following regarding Western Digital Corporation (NASDAQ:WDC) in its Q2 2024 investor letter: 'We re-initiated a position in Western Digital Corporation (NASDAQ:WDC), a manufacturer of memory semiconductor chips and hard disk drives, as we believe earnings expectations are far too low. Semiconductors have been another of our most-alpha-generative industries, thanks to the industry's secular tailwinds and our in-house expertise. Western Digital stands to benefit from the rapid growth of memory-hungry AI applications. The valuation for Western Digital was low relative to its peers, giving us a way to participate in AI at a reasonable valuation.' Overall, WDC ranks 7th on our list of billionaire Larry Robbins' stock picks with huge upside potential. While we acknowledge the potential of WDC as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than WDC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-05-2025
- Business
- Yahoo
Element Solutions Inc (ESI): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Larry Robbins' 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Element Solutions Inc (NYSE:ESI) stands against other stock picks with huge upside potential. Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000. The firm manages capital for investors across a range of private investment funds. Robbins is currently the CEO of his firm. He graduated with honors from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania in 1992 and earned a BS in economics with concentrations in accounting, finance, and marketing. He also has a BS in engineering with a major in systems engineering. He became a Certified Public Accountant in Illinois in 1991. Before founding Glenview Capital, Robbins worked as a portfolio manager at Omega Advisors, which is a prominent hedge fund founded by Leon Cooperman. In 2017, Larry Robbins also began serving as chairman of the Robin Hood Foundation, which fights poverty in New York City. Through his Family Foundation, he is an active supporter of education reform both in NYC and on the national level. He also serves as Chairman of the Board of KIPP NY and is a Board Member of Zearn and Relay Graduate School of Education. Due to his sharp analytical skills and a focus on the healthcare sector, Robbins has built a reputation as one of the most influential figures in the hedge fund industry. Glenview Capital Management has 6 clients and discretionary assets under management (AUM) of $5.6 billion as reported in its Form ADV dated 4 March 2025. The last reported 13F filing for Q4 2024 included $3.95 billion in managed 13F securities and a top 10 holdings concentration of 65.22%. Earlier in September 2024, Institutional Investor reported that Glenview Capital Management was on track for its best year in 5 years. The flagship Glenview Capital Partners fund was up 3.45% in August 2024 and 17.2% through the first 8 months of the year. One of the reasons behind this performance is the hedge fund's diversification away from a historically heavy concentration in healthcare stocks. Glenview Capital Management has now expanded its investments into the tech sector and other industries. Larry Robbins believes in a straightforward investment strategy: 'There are only two things that matter in investing. What are they going to earn, and what multiple are people going to put on that. Let's not make our business any more complicated than this.' To compile the list of billionaire Larry Robbins' 10 stock picks with huge upside potential, we sifted through Q4 2024 13F filings of Glenview Capital from Insider Monkey. From these filings, we checked the upside potential from CNN for the top 30 stock picks and ranked the stocks in ascending order of this upside potential. We have also added Glenview Capital's stake in each stock as well as the broader hedge fund sentiment for it. Note: All data was sourced on May 8. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). An industrial worker in a protective suit operating a complex chemical process.I Glenview Capital's Stake: $62.32 million Number of Hedge Fund Holders: 51 Average Upside Potential as of May 8: 26.61% Element Solutions Inc (NYSE:ESI) is a specialty chemicals company. Its Electronics segment provides assembly solutions, like surface mount technologies, fluxes, thermal management materials, and other attachment materials. The Industrial & Specialty segment offers industrial solutions like electroless nickel, plating products, pre-treatment & cleaning solutions, and water treatment. In Q1 2025, the Electronics segment grew 10% organically year-over-year due to historically higher-margin categories in circuitry and semiconductor, as well as assembly materials for consumer electronics. This translated to a 9% growth in adjusted EBITDA for the segment. Within Electronics, the sales from wafer-level packaging products also surged by ~20% due to the ramp-up of programs on leading-edge nodes. The Semiconductor Solutions business achieved a 17% organic net sales growth due to the demand in wafer-level packaging for semi-fab OSAT customers in Asia. The viaform copper-damaging product line particularly grew ~20% in the quarter. Element Solutions Inc (NYSE:ESI) is also increasing manufacturing capacity for future growth areas like nano copper and power electronics. It's also building research and applications development in high-leverage geographies. The London Company SMID Cap Strategy stated the following regarding Element Solutions Inc (NYSE:ESI) in its Q4 2024 investor letter: 'Initiated: Element Solutions Inc (NYSE:ESI) – ESI is a specialty chemicals producer serving electronics and industrial markets. Electronics is ESI's primary growth engine, supported by content growth in circuit boards, semiconductors, and EV markets. A variable cost structure and sticky, spec'd-in products bolster earnings stability across cycles. ESI offers consistent cash flow and benefits from strong capital allocation led by management aligned with long-term incentives. More recently, management has been divesting non-core assets and reinvesting back into its growth segments. Trading at an attractive discount to intrinsic value, we believe ESI offers upside from a recovering electronics cycle, margin expansion from improved product mix, and pricing power due to high customer switching costs.' Overall, ESI ranks 9th on our list of billionaire Larry Robbins' stock picks with huge upside potential. While we acknowledge the potential of ESI as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ESI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-05-2025
- Business
- Yahoo
Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Larry Robbins' 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other stock picks with huge upside potential. Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000. The firm manages capital for investors across a range of private investment funds. Robbins is currently the CEO of his firm. He graduated with honors from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania in 1992 and earned a BS in economics with concentrations in accounting, finance, and marketing. He also has a BS in engineering with a major in systems engineering. He became a Certified Public Accountant in Illinois in 1991. Before founding Glenview Capital, Robbins worked as a portfolio manager at Omega Advisors, which is a prominent hedge fund founded by Leon Cooperman. In 2017, Larry Robbins also began serving as chairman of the Robin Hood Foundation, which fights poverty in New York City. Through his Family Foundation, he is an active supporter of education reform both in NYC and on the national level. He also serves as Chairman of the Board of KIPP NY and is a Board Member of Zearn and Relay Graduate School of Education. Due to his sharp analytical skills and a focus on the healthcare sector, Robbins has built a reputation as one of the most influential figures in the hedge fund industry. Glenview Capital Management has 6 clients and discretionary assets under management (AUM) of $5.6 billion as reported in its Form ADV dated 4 March 2025. The last reported 13F filing for Q4 2024 included $3.95 billion in managed 13F securities and a top 10 holdings concentration of 65.22%. Earlier in September 2024, Institutional Investor reported that Glenview Capital Management was on track for its best year in 5 years. The flagship Glenview Capital Partners fund was up 3.45% in August 2024 and 17.2% through the first 8 months of the year. One of the reasons behind this performance is the hedge fund's diversification away from a historically heavy concentration in healthcare stocks. Glenview Capital Management has now expanded its investments into the tech sector and other industries. Larry Robbins believes in a straightforward investment strategy: 'There are only two things that matter in investing. What are they going to earn, and what multiple are people going to put on that. Let's not make our business any more complicated than this.' To compile the list of billionaire Larry Robbins' 10 stock picks with huge upside potential, we sifted through Q4 2024 13F filings of Glenview Capital from Insider Monkey. From these filings, we checked the upside potential from CNN for the top 30 stock picks and ranked the stocks in ascending order of this upside potential. We have also added Glenview Capital's stake in each stock as well as the broader hedge fund sentiment for it. Note: All data was sourced on May 8. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). A close-up shot of various types of medicines on a table, illustrating the specialty and generic products offered by the pharmaceutical company. Glenview Capital's Stake: $186.38 million Number of Hedge Fund Holders: 72 Average Upside Potential as of May 8: 27.84% Teva Pharmaceutical Industries Limited (NYSE:TEVA) develops, manufactures, markets, and distributes generic and other medicines and biopharmaceutical products. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It focuses on the central nervous system, respiratory, and oncology areas. The company has a focus on AUSTEDO, which is a prescription medicine that is used to treat involuntary movements caused by tardive dyskinesia and Huntington's disease. Revenue for AUSTEDO was up 34% in 2024 and reached ~$1.7 billion. In the US, AUSTEDO generated $1.642 billion in revenue, which marked an improvement of 34% in TRx (total prescriptions). Teva Pharmaceutical Industries Limited (NYSE:TEVA) is confident in AUSTEDO's success and projects revenues between $1.9 and ~$2 billion for 2025. This sentiment comes from the unmet medical need in tardive dyskinesia, where only 6% of the 800,000 patients are currently on treatment. Sound Shore Management stated the following regarding Teva Pharmaceutical Industries Limited (NYSE:TEVA) in its Q4 2024 investor letter: 'Teva Pharmaceutical Industries Limited (NYSE:TEVA): Traditionally known as a generic drug company, Teva has a growing branded drug business and a promising pipeline. Following a period of poor capital allocation decisions by prior management teams, we were able to invest at a very attractive 4 times earnings and with a 20%+ free cash flow yield. New leadership has focused on execution and pipeline development, leading to upward inflection in margins and positive clinical trial results. Teva remains remarkably cheap, trading at a significant discount to its intrinsic value. (Please see our 2Q 2024 letter for a more in-depth review of Teva.)' Overall, TEVA ranks 8th on our list of billionaire Larry Robbins' stock picks with huge upside potential. While we acknowledge the potential of TEVA as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than TEVA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
